<http://webisa.webdatacommons.org/224130297>	<http://www.w3.org/ns/prov#value>	"The Company's lead candidate is in development as a metabolically inert treatment alternative to Methotrexate for rheumatoid arthritis, psoriasis, and other disorders." .
<http://webisa.webdatacommons.org/prov/412970331>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/224130297> .
<http://webisa.webdatacommons.org/224130297>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<tmcnet.com> .
<http://webisa.webdatacommons.org/224130297>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .